Jharkhand
Jharkhand Ties Up with Indian Pharmacopoeia Commission (IPC)
- 17 Nov 2025
- 2 min read
Why in News?
The Indian Pharmacopoeia Commission (IPC) signed an MoU with the Jharkhand State Pharmacy Council (JSPC) to strengthen pharmacovigilance systems across Jharkhand.
Key Points
- About the Agreement:
- The MoU aims to strengthen the safe and rational use of medicines in the state by improving pharmacovigilance (drug safety monitoring) and materiovigilance (medical device safety).
- The agreement promotes wider adoption of the National Formulary of India (NFI) as a standard reference across healthcare institutions to support rational medication practices.
- Indian Pharmacopoeia Commission (IPC) will provide technical expertise, while Jharkhand State Pharmacy Council (JSPC) will mobilise pharmacists from public and private sectors to ensure effective implementation.
- About Indian Pharmacopoeia Commission (IPC):
- IPC is an autonomous institution under the Ministry of Health & Family Welfare.
- It publishes the Indian Pharmacopoeia (IP), the official book of drug standards in India.
- It operates the Pharmacovigilance Programme of India (PvPI) and Materiovigilance Programme of India (MvPI).
- It promotes patient safety, drug quality surveillance, and evidence-based medicine use.
- About National Formulary of India (NFI):
- It is an official reference published by the Indian Pharmacopoeia Commission (IPC) to guide the rational and safe use of medicines.
- It provides standard information on approved drugs, including indications, dosages, contraindications and adverse effects, promoting uniform and evidence-based prescribing.
